nsv6314621
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:complex chromosomal rearrangement
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:1
- Description:
46;XX;inv(5)(p12q13.1)dn AND multiple conditions - Publication(s):Manickam et al. 2021, Michelson et al. 2011, Redin et al. 2016
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 93 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 93 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 87 SVs from 19 studies. See in: genome view
Overlapping variant regions from other studies: 87 SVs from 19 studies. See in: genome view
Overlapping variant regions from other studies: 93 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 93 SVs from 29 studies. See in: genome view
Overlapping variant regions from other studies: 87 SVs from 19 studies. See in: genome view
Overlapping variant regions from other studies: 87 SVs from 19 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
---|---|---|---|---|---|---|---|---|---|---|
nsv6314621 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 24,272,189 | 24,272,189 | - |
nsv6314621 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 24,272,193 | 24,272,193 | + |
nsv6314621 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 89,105,026 | 89,105,026 | - |
nsv6314621 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000005.10 | Chr5 | 89,105,031 | 89,105,031 | + |
nsv6314621 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 24,272,298 | 24,272,298 | - | ||
nsv6314621 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 24,272,302 | 24,272,302 | + | ||
nsv6314621 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 88,400,843 | 88,400,843 | - | ||
nsv6314621 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000005.9 | Chr5 | 88,400,848 | 88,400,848 | + |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17975739 | inversion | Multiple | Multiple | Autistic behavior; Autistic behavior; Global developmental delay; Global developmental delay; Hypotonia; Muscular hypotonia; Seizure; Seizures | Likely pathogenic | ClinVar | RCV000258677.1, VCV000267886.1 |
nssv17975738 | inversion | Multiple | Multiple | Autistic behavior; Autistic behavior; Global developmental delay; Global developmental delay; Hypotonia; Muscular hypotonia; Seizure; Seizures | Likely pathogenic | ClinVar | RCV000258677.1, VCV000267886.1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
nssv17975739 | Remapped | Perfect | NC_000005.10:g.891 05031inv230NC_0000 05.10:g.24272189in v230 | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 24,272,189 | 24,272,189 |
nssv17975738 | Remapped | Perfect | NC_000005.10:g.891 05026inv227NC_0000 05.10:g.24272193in v227 | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 24,272,193 | 24,272,193 |
nssv17975738 | Remapped | Perfect | NC_000005.10:g.891 05026inv227NC_0000 05.10:g.24272193in v227 | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 89,105,026 | 89,105,026 |
nssv17975739 | Remapped | Perfect | NC_000005.10:g.891 05031inv230NC_0000 05.10:g.24272189in v230 | GRCh38.p12 | First Pass | NC_000005.10 | Chr5 | 89,105,031 | 89,105,031 |
nssv17975739 | Submitted genomic | NC_000005.9:g.2427 2298inv230NC_00000 5.9:g.88400848inv2 30 | GRCh37 (hg19) | NC_000005.9 | Chr5 | 24,272,298 | 24,272,298 | ||
nssv17975738 | Submitted genomic | NC_000005.9:g.2427 2302inv227NC_00000 5.9:g.88400843inv2 27 | GRCh37 (hg19) | NC_000005.9 | Chr5 | 24,272,302 | 24,272,302 | ||
nssv17975738 | Submitted genomic | NC_000005.9:g.2427 2302inv227NC_00000 5.9:g.88400843inv2 27 | GRCh37 (hg19) | NC_000005.9 | Chr5 | 88,400,843 | 88,400,843 | ||
nssv17975739 | Submitted genomic | NC_000005.9:g.2427 2298inv230NC_00000 5.9:g.88400848inv2 30 | GRCh37 (hg19) | NC_000005.9 | Chr5 | 88,400,848 | 88,400,848 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17975739 | GRCh37: NC_000005.9:g.24272298inv230NC_000005.9:g.88400848inv230 | inversion | de novo | Autistic behavior; Autistic behavior; Global developmental delay; Global developmental delay; Hypotonia; Muscular hypotonia; Seizure; Seizures | Likely pathogenic | ClinVar | RCV000258677.1, VCV000267886.1 |
nssv17975738 | GRCh37: NC_000005.9:g.24272302inv227NC_000005.9:g.88400843inv227 | inversion | de novo | Autistic behavior; Autistic behavior; Global developmental delay; Global developmental delay; Hypotonia; Muscular hypotonia; Seizure; Seizures | Likely pathogenic | ClinVar | RCV000258677.1, VCV000267886.1 |